Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Estiverne, M.D.

Concepts (18)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Gout220205730.930 Why?
Organic Anion Transporters120201000.720 Why?
Hyperuricemia120202110.610 Why?
Allopurinol120201910.170 Why?
Gout Suppressants120201660.170 Why?
Uric Acid120207660.120 Why?
Lupus Nephritis120153100.100 Why?
Homeostasis1202033400.090 Why?
Biological Products120158600.070 Why?
Immunosuppressive Agents1201541490.050 Why?
Genome-Wide Association Study12020122610.050 Why?
Remission Induction1201523860.020 Why?
Humans320207443430.020 Why?
Drug Therapy, Combination1201564890.020 Why?
Recurrence1201583400.010 Why?
Disease Progression12015132840.010 Why?
Treatment Outcome12015631140.010 Why?
Risk Factors12015722900.010 Why?
Estiverne's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (18)
Explore
_
Co-Authors (13)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.